HOFBF
Price
$0.17
Change
+$0.01 (+6.25%)
Updated
Jul 7 closing price
Capitalization
67.77M
IPHYF
Price
$1.31
Change
-$0.64 (-32.82%)
Updated
Jul 7 closing price
Capitalization
195.28M
Interact to see
Advertisement

HOFBF vs IPHYF

Header iconHOFBF vs IPHYF Comparison
Open Charts HOFBF vs IPHYFBanner chart's image
Hofseth Biocare ASA
Price$0.17
Change+$0.01 (+6.25%)
Volume$10K
Capitalization67.77M
Innate Pharma
Price$1.31
Change-$0.64 (-32.82%)
Volume$450
Capitalization195.28M
HOFBF vs IPHYF Comparison Chart in %
Loading...
HOFBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPHYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOFBF vs. IPHYF commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOFBF is a Hold and IPHYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (HOFBF: $0.17 vs. IPHYF: $1.31)
Brand notoriety: HOFBF and IPHYF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOFBF: 192% vs. IPHYF: 58%
Market capitalization -- HOFBF: $67.77M vs. IPHYF: $195.28M
HOFBF [@Biotechnology] is valued at $67.77M. IPHYF’s [@Biotechnology] market capitalization is $195.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOFBF’s FA Score shows that 0 FA rating(s) are green whileIPHYF’s FA Score has 0 green FA rating(s).

  • HOFBF’s FA Score: 0 green, 5 red.
  • IPHYF’s FA Score: 0 green, 5 red.
According to our system of comparison, HOFBF is a better buy in the long-term than IPHYF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOFBF’s TA Score shows that 1 TA indicator(s) are bullish while IPHYF’s TA Score has 5 bullish TA indicator(s).

  • HOFBF’s TA Score: 1 bullish, 1 bearish.
  • IPHYF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IPHYF is a better buy in the short-term than HOFBF.

Price Growth

HOFBF (@Biotechnology) experienced а 0.00% price change this week, while IPHYF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.15%. For the same industry, the average monthly price growth was +8.44%, and the average quarterly price growth was +12.41%.

Industries' Descriptions

@Biotechnology (+1.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPHYF($195M) has a higher market cap than HOFBF($67.8M). HOFBF YTD gains are higher at: 66.600 vs. IPHYF (-54.828).
HOFBFIPHYFHOFBF / IPHYF
Capitalization67.8M195M35%
EBITDA-73.54MN/A-
Gain YTD66.600-54.828-121%
P/E RatioN/AN/A-
Revenue266MN/A-
Total Cash71.9MN/A-
Total Debt236MN/A-
FUNDAMENTALS RATINGS
HOFBF vs IPHYF: Fundamental Ratings
HOFBF
IPHYF
OUTLOOK RATING
1..100
3839
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
4393
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IPHYF's Valuation (71) in the null industry is in the same range as HOFBF (85). This means that IPHYF’s stock grew similarly to HOFBF’s over the last 12 months.

IPHYF's Profit vs Risk Rating (100) in the null industry is in the same range as HOFBF (100). This means that IPHYF’s stock grew similarly to HOFBF’s over the last 12 months.

IPHYF's SMR Rating (95) in the null industry is in the same range as HOFBF (99). This means that IPHYF’s stock grew similarly to HOFBF’s over the last 12 months.

HOFBF's Price Growth Rating (43) in the null industry is somewhat better than the same rating for IPHYF (93). This means that HOFBF’s stock grew somewhat faster than IPHYF’s over the last 12 months.

HOFBF's P/E Growth Rating (100) in the null industry is in the same range as IPHYF (100). This means that HOFBF’s stock grew similarly to IPHYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOFBFIPHYF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
38%
Bullish Trend 2 days ago
50%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
31%
Bullish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
15%
Bullish Trend 2 days ago
45%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
13%
Bullish Trend 2 days ago
40%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
60%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
HOFBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPHYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSHZY9.150.42
+4.81%
Hoshizaki Corporation
DNTCF5.970.01
+0.10%
DENTALCORP HLDGS LTD
MMILF0.05N/A
N/A
Metro Mining Ltd.
CANOF0.30N/A
-0.64%
California Nanotechnologies Corp
RSMDF16.66-8.11
-32.74%
Resmed Inc.

HOFBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOFBF has been loosely correlated with BIVI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HOFBF jumps, then BIVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOFBF
1D Price
Change %
HOFBF100%
N/A
BIVI - HOFBF
44%
Loosely correlated
-21.17%
PHGE - HOFBF
35%
Loosely correlated
+49.43%
INNMF - HOFBF
23%
Poorly correlated
-19.06%
GOVX - HOFBF
3%
Poorly correlated
-9.39%
IPHYF - HOFBF
1%
Poorly correlated
N/A
More

IPHYF and

Correlation & Price change

A.I.dvisor tells us that IPHYF and KNBIF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPHYF and KNBIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHYF
1D Price
Change %
IPHYF100%
N/A
KNBIF - IPHYF
6%
Poorly correlated
-18.21%
INNMF - IPHYF
6%
Poorly correlated
-19.06%
OTLC - IPHYF
4%
Poorly correlated
-9.43%
ISCO - IPHYF
1%
Poorly correlated
N/A
LIXT - IPHYF
1%
Poorly correlated
+2.28%
More